146 related articles for article (PubMed ID: 37303578)
1. Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway.
Qian X; Cai J; Qi Q; Han J; Zhu X; Xia R; Zhang Q
Heliyon; 2023 Jun; 9(6):e16696. PubMed ID: 37303578
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
3. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract][Full Text] [Related]
4. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
5. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
12. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
14. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
[TBL] [Abstract][Full Text] [Related]
15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
16. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
17. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study.
Shu YJ; Weng H; Bao RF; Wu XS; Ding Q; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Li ML; Mu JS; Wu WG; Liu YB
BMC Cancer; 2014 Aug; 14():566. PubMed ID: 25096189
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway" [Heliyon
Qian X; Cai J; Qi Q; Han J; Zhu X; Xia R; Zhang Q
Heliyon; 2023 Sep; 9(9):e19952. PubMed ID: 37809970
[TBL] [Abstract][Full Text] [Related]
20. The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.
Zhang X; Wu Y; Sun X; Cui Q; Bai X; Dong G; Gao Z; Wang Y; Gao C; Sun S; Ji N; Liu Y
BMC Cancer; 2022 Feb; 22(1):190. PubMed ID: 35184749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
